Literature DB >> 24259046

Do consumers of manufactured cigarettes respond differently to price changes compared with their Roll-Your-Own counterparts? Evidence from New Zealand.

Peter Tait1, Paul Rutherford1, Caroline Saunders1.   

Abstract

BACKGROUND: Price-based mechanisms are an important tobacco cessation policy tool in New Zealand (NZ) and so measurement of smokers' reaction to price changes is crucial in determining efficacy of this approach. Although approximately two-thirds of NZ tobacco demand is for manufactured cigarettes (MC) and one-third is for Roll-Your-Own (RYO) tobacco, previous price elasticity estimates have ignored differences between RYO tobacco and MC consumers.
METHODS: We employ a seemingly unrelated regression econometric approach applied to quarterly data over the period 1991-2011 to estimate price elasticities of demand separately for MC and RYO tobacco.
RESULTS: Estimate of price elasticity of demand for MC is -1.033, and -0.441 for RYO tobacco. RYO tobacco is an inferior good; a 1% increase in average weekly income is associated with a 0.8% reduction in demand. RYO tobacco is a substitute for MC; a 1% increase in the price of MC is associated with a 0.867% increase in demand for RYO tobacco.
CONCLUSIONS: There is significantly different price responsiveness across the two tobacco product types. MC smokers react far more strongly to price increases compared with RYO tobacco smokers. These findings suggest that pricing mechanisms may be more effective for reducing MC demand than for RYO tobacco. However, substitution between products means that this pricing effect is muted by the uptake of RYO tobacco use. Cessation policy specific to RYO use should be designed to target this growing group. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Economics; End game; Price; Taxation

Mesh:

Year:  2013        PMID: 24259046     DOI: 10.1136/tobaccocontrol-2013-051010

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  6 in total

1.  Transitions from and to roll-your-own tobacco, perceptions and health beliefs among smokers: findings from the EUREST-PLUS ITC Europe Surveys.

Authors:  Filippos T Filippidis; Pete Driezen; Christina N Kyriakos; Paraskevi Katsaounou; Ioanna Petroulia; Charis Girvalaki; Marcela Fu; Esteve Fernández; Ute Mons; Antigona C Trofor; Tibor Demjén; Krzysztof Przewoźniak; Witold A Zatoński; Geoffrey T Fong; Yannis Tountas; Constantine I Vardavas
Journal:  Eur J Public Health       Date:  2020-07-01       Impact factor: 3.367

2.  Price, tax and tobacco product substitution in Zambia: findings from the ITC Zambia Surveys.

Authors:  Michal Stoklosa; Fastone Goma; Nigar Nargis; Jeffrey Drope; Grieve Chelwa; Zunda Chisha; Geoffrey T Fong
Journal:  Tob Control       Date:  2018-03-24       Impact factor: 7.552

3.  A comprehensive examination of own- and cross-price elasticities of tobacco and nicotine replacement products in the U.S.

Authors:  Jidong Huang; Cezary Gwarnicki; Xin Xu; Ralph S Caraballo; Roy Wada; Frank J Chaloupka
Journal:  Prev Med       Date:  2018-04-21       Impact factor: 4.018

4.  Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis.

Authors:  Mohammed Jawad; John Tayu Lee; Stanton Glantz; Christopher Millett
Journal:  Tob Control       Date:  2018-01-23       Impact factor: 7.552

5.  Smokers' strategies across social grades to minimise the cost of smoking in a period with annual tax increases: evidence from a national survey in England.

Authors:  Mirte Ag Kuipers; Timea Partos; Ann McNeill; Emma Beard; Anna B Gilmore; Robert West; Jamie Brown
Journal:  BMJ Open       Date:  2019-06-25       Impact factor: 2.692

6.  Tobacco industry strategies undermine government tax policy: evidence from commercial data.

Authors:  Rosemary Hiscock; J Robert Branston; Ann McNeill; Sara C Hitchman; Timea R Partos; Anna B Gilmore
Journal:  Tob Control       Date:  2017-10-09       Impact factor: 7.552

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.